my.naviGATE for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new app called my.naviGATE, designed to help young people with cancer manage their treatment and recovery. The app offers custom education, connects users with peers, and tracks health reports. Participants will either use the app or receive standard cancer care to evaluate the app's effectiveness. The trial seeks teens and young adults, aged 15-24, currently undergoing specific cancer treatments like chemotherapy or radiation for cancers such as leukemia or sarcoma. As an unphased trial, this study provides a unique opportunity to contribute to innovative cancer care solutions.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current cancer treatment while participating, as the study is designed for those actively receiving therapy.
What prior data suggests that the my.naviGATE digital tool is safe for adolescents and young adults with cancer?
Research has shown that digital tools like the my.naviGATE app are generally safe and user-friendly. Studies on similar tools for cancer patients have found that they assist in navigating the healthcare system without causing significant side effects. For instance, these digital tools have improved communication between patients and healthcare providers, which is crucial for effective treatment management.
Designed to help patients manage their care and access information, these tools do not involve medication or physical treatments, reducing the risk of direct negative effects. Although specific safety data for the my.naviGATE app is not available, the overall safety of digital health tools in cancer care suggests they are unlikely to cause harm.12345Why are researchers excited about this trial?
Researchers are excited about the my.naviGATE digital tool because it offers a personalized approach to cancer care that differs from standard treatments like chemotherapy or radiation. This tool integrates digital technology to help manage and track patient progress through surveys and virtual interviews, which can lead to more tailored and responsive care. By focusing on patient feedback and engagement, my.naviGATE aims to improve the overall treatment experience and potentially enhance outcomes by adapting care plans based on real-time data.
What evidence suggests that the my.naviGATE digital tool is effective for cancer?
Studies have shown that digital tools like my.naviGATE, available to participants in this trial, can enhance cancer care by enabling healthcare providers to respond swiftly to patient needs. Clinics using similar platforms often achieve over a 30% improvement in resolving patient issues. Research indicates that these tools help reduce hospital visits by effectively managing side effects and other complications. They also enhance communication between patients and healthcare providers, resulting in more personalized care. Essentially, my.naviGATE supports young people with cancer by offering tailored education and connecting them with others who understand their experiences.26789
Who Is on the Research Team?
Katie Greenzang, MD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for teens and young adults (ages 15-24) currently getting treatment for certain cancers like leukemia, lymphoma, sarcomas, or medulloblastoma at specific hospitals. Participants must be able to speak and read English and have a chance of cure.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the my.naviGATE app for personalized survivorship education and virtual peer navigation
Usual Care
Participants receive standard oncology care and complete surveys
Follow-up
Participants are monitored for self-efficacy, HRQoL, and other outcomes post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- my.naviGATE Digital Tool
Trial Overview
The study is testing my.naviGATE, a mobile app that gives personalized education about life after cancer treatment, connects users with peer support online, and tracks their health through self-reported updates.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be randomized in a 1:1 ratio to this study group and will complete the following: * Baseline survey * 1 month survey * 6 month survey * Virtual interview (subset of participants)
Participants will be randomized in a 1:1 ratio to this study group and will receive standard oncology care and will complete the following: * Baseline survey * 1 month survey * 6 month survey
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
Hyundai Hope On Wheels
Collaborator
Citations
Outcomes & Insights
Clinics using our platform respond more quickly to patient issues and regularly see a 30%+ improvement in incident resolution times.
The Effect of Nurse Navigators in Digital Remote Monitoring in ...
This report focuses on patients in the CAPRI arm, evaluating the impact of NN interventions on outcomes such as toxicity, hospitalization, and emergency visits.
3.
jons-online.com
jons-online.com/issues/2025/march-2025-vol-16-no-3/evaluating-the-effectiveness-of-the-national-oncology-navigation-acuity-toolEvaluating the Effectiveness of the National Oncology ...
Researchers who evaluated the versatility and efficacy of the National Oncology Navigation Acuity Tool share their findings and suggest that the tool could ...
4.
prescancerpanel.cancer.gov
prescancerpanel.cancer.gov/reports-meetings/enhancing-patient-navigation-2024/executive-summaryExecutive Summary - Enhancing Patient Navigation with ...
In this report, the Panel identifies ways technology could be used to enhance evidence-based patient navigation for people with cancer.
Oncology Navigation Platforms: Improving Patient Outcomes
This guide covers how these platforms work, the features that matter most, and what to look for when evaluating solutions for your cancer ...
Patient Navigation in Cancer Treatment: A Systematic Review
The findings suggest that patient navigation plays a crucial role in improving access to care and optimizing treatment outcomes, especially for disadvantaged ...
Patient data access increases, supports healthcare ...
Cancer patients have higher digital patient engagement than their peers with no history of cancer, with new data from the Assistant ...
User-Centered Design for Digital Patient-Navigation Tools in ...
Eligible studies reported original, peer-reviewed research on digital or mobile health interventions linked to cancer navigation and documented ...
Patient Navigation | Cancer
Identify what data will be needed. Use the Patient Navigation Barriers and Outcomes Tool developed by George Washington University as a guide.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.